METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough pancreatic cancer: experimental combo targets Cancer's repair system
Disease control CompletedThis study tested whether adding a new drug called ABT-888 to standard chemotherapy could better control metastatic pancreatic cancer. The trial enrolled 64 patients whose cancer had spread and who had specific genetic risk factors or family cancer history. ABT-888 works by block…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Doctors track which chemo works best for tough pancreatic cancer
Knowledge-focused CompletedThis study observed how doctors choose chemotherapy treatments for patients with advanced pancreatic cancer that cannot be surgically removed. Researchers followed 799 patients in Korea for one year to see which drug combinations were used, why they were chosen, and how patients …
Matched conditions: METASTATIC PANCREATIC CANCER
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC